Roles of the matrix metalloproteinases in mammary gland development and cancer

被引:112
作者
Benaud, C
Dickson, RB
Thompson, EW
机构
[1] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Dept Pharmacol, Washington, DC 20007 USA
[2] Georgetown Univ, Med Ctr, Dept Cell Biol, Washington, DC 20007 USA
[3] Georgetown Univ, Med Ctr, Dept Orthoped Surg, Washington, DC 20007 USA
关键词
MMP; breast development; breast cancer;
D O I
10.1023/A:1006061115909
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue remodeling is a key process involved in normal development, wound healing, bone remodeling, and embryonic implantation, as well as pathological conditions such as tumor invasion and metastasis, and angiogenesis. The degradation of the extracellular matrix that is associated with those processes is mediated by a number of families of extracellular proteinases. These families include the serine proteinases, such as the plasminogen-urokinase plasminogen activator system and leukocyte elastases, the cysteine proteinases, like cathepsin D and L, and the zinc-dependent matrix metalloproteinases (MMPs) [1]. Accumulating evidence has highlighted the central role of MMP-driven extracellular matrix remodeling in mammary gland development and breast cancer.
引用
收藏
页码:97 / 116
页数:20
相关论文
共 144 条
  • [1] MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS
    AIMES, RT
    QUIGLEY, JP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) : 5872 - 5876
  • [2] Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene
    Alexander, CM
    Howard, EW
    Bissell, MJ
    Werb, Z
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 135 (06) : 1669 - 1677
  • [3] Alexander CM, 1991, CELL BIOL EXTRACELLU, P255
  • [4] Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor
    An, ZL
    Wang, XE
    Willmott, N
    Chander, SK
    Tickle, S
    Docherty, AJP
    Mountain, A
    Millican, AT
    Morphy, R
    Porter, JR
    Epemolu, RO
    Kubota, T
    Moossa, AR
    Hoffman, RM
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (02) : 184 - 195
  • [5] STRUCTURE AND PROMOTER CHARACTERIZATION OF THE HUMAN STROMELYSIN-3 GENE
    ANGLARD, P
    MELOT, T
    GUERIN, E
    THOMAS, G
    BASSET, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) : 20337 - 20344
  • [6] ASSOCIATION OF MMP-2 ACTIVATION POTENTIAL WITH METASTATIC PROGRESSION IN HUMAN BREAST-CANCER CELL-LINES INDEPENDENT OF MMP-2 PRODUCTION
    AZZAM, HS
    ARAND, G
    LIPPMAN, ME
    THOMPSON, EW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (21) : 1758 - 1764
  • [7] Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ
    Bartlett, JD
    Simmer, JP
    Xue, J
    Margolis, HC
    Moreno, EC
    [J]. GENE, 1996, 183 (1-2) : 123 - 128
  • [8] A NOVEL METALLOPROTEINASE GENE SPECIFICALLY EXPRESSED IN STROMAL CELLS OF BREAST CARCINOMAS
    BASSET, P
    BELLOCQ, JP
    WOLF, C
    STOLL, I
    HUTIN, P
    LIMACHER, JM
    PODHAJCER, OL
    CHENARD, MP
    RIO, MC
    CHAMBON, P
    [J]. NATURE, 1990, 348 (6303) : 699 - 704
  • [9] THE EFFECT OF PLATELETS ON INVASIVENESS AND PROTEASE PRODUCTION OF HUMAN MAMMARY-TUMOR CELLS
    BELLOC, C
    LU, H
    SORIA, C
    FRIDMAN, R
    LEGRAND, Y
    MENASHI, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (03) : 413 - 417
  • [10] BENELLI R, 1994, ONCOL RES, V6, P251